Cost effectiveness analysis of smoking cessation interventions
- 1 October 2006
- journal article
- review article
- Published by Elsevier in Australian and New Zealand Journal of Public Health
- Vol. 30 (5) , 428-434
- https://doi.org/10.1111/j.1467-842x.2006.tb00458.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effectiveness of Bupropion Sustained Release for Smoking Cessation in a Health Care SettingArchives of internal medicine (1960), 2003
- Measures of abstinence in clinical trials: issues and recommendationsNicotine & Tobacco Research, 2003
- Efficacy and Cost-Effectiveness Analysis of NRT Patches vs. Once-Daily Bupropion SR: A Retrospective Chart ReviewJournal of Pharmacy Technology, 2001
- Cost-Benefit Analysis of Sustained-Release Bupropion, Nicotine Patch, or Both for Smoking CessationPreventive Medicine, 2000
- Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectivenessThe Lancet, 1999
- A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking CessationNew England Journal of Medicine, 1999
- Cost-effectiveness of the Clinical Practice Recommendations in the AHCPR Guideline for Smoking CessationJAMA, 1997
- Cost Effectiveness of Smoking-Cessation TherapiesPharmacoEconomics, 1997
- The Cost-Effectiveness of the Nicotine Transdermal Patch for Smoking CessationPreventive Medicine, 1997
- Meta-analysis on efficacy of nicotine replacement therapies in smoking cessationThe Lancet, 1994